<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-157076" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Eosinophilic Pustular Folliculitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dodia</surname>
            <given-names>Paarth</given-names>
          </name>
          <aff>Campbell University/Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cook</surname>
            <given-names>Christopher</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Paarth Dodia declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Cook declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>28</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-157076.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Eosinophilic pustular folliculitis (EPF), first reported in 1965 and previously known as Ofuji disease, is a rare dermatological condition found across diverse patient populations.<xref ref-type="bibr" rid="article-157076.r1">[1]</xref> EPF comprises three distinct subtypes: EPF of infancy (EPFI), classic EPF of adulthood (EPF), and immunosuppression-associated EPF (IS-EPF). All three subtypes are characterized by a pruritic pustular skin eruption with a noninfectious origin and histological eosinophilic infiltrates. However, despite these similarities, treatment approaches and prognoses vary with each subtype.</p>
        <p>This activity will review the epidemiology, proposed etiologies, presumptive pathophysiological processes, typical clinical presentation, evaluation, and management of EPF and highlight the role of the interprofessional team in caring for patients with this dermatological condition.</p>
      </sec>
      <sec id="article-157076.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of EPF is unknown, although multiple theories have been proposed.</p>
        <p>Genetic predisposition may increase the risk of developing EPF, and studies have identified immunohistochemical markers that may be indicative of increased risk.<xref ref-type="bibr" rid="article-157076.r2">[2]</xref>&#x000a0;Further studies are needed to elucidate contributing genetic factors.</p>
        <p>An immunological etiology of EPF has been proposed based on the high prevalence of EPF cases in patients living with the human immunodeficiency virus (HIV).<xref ref-type="bibr" rid="article-157076.r3">[3]</xref>&#x000a0;Additionally, studies of solid organ or hematopoietic transplant recipients receiving immunosuppressive therapy demonstrate an increased incidence of EPF.<xref ref-type="bibr" rid="article-157076.r4">[4]</xref><xref ref-type="bibr" rid="article-157076.r5">[5]</xref>&#x000a0;The eosinophilic infiltrates characteristic of all forms of EPF typically indicate allergic and inflammatory responses, and it is hypothesized that an aberrant immune response triggers this eosinophilic inflammation. There are also reports of EPF developing in a typical medication-related adverse event scenario.<xref ref-type="bibr" rid="article-157076.r6">[6]</xref><xref ref-type="bibr" rid="article-157076.r4">[4]</xref></p>
        <p>The fact that EPF responds to such a diverse array of treatment modalities, including immunosuppressive medications, antimicrobials, and phototherapy, suggests the underlying etiologies of EPF may vary or be multifactorial. The intricate interplay between immune dysregulation, microbial factors, and genetic susceptibility necessitates further investigation to unravel the complex etiologic mechanisms and facilitate treatment regimens.</p>
      </sec>
      <sec id="article-157076.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>EPF is a rare disorder with a wide geographic distribution, although it is most frequently reported in Japan. The prevalence in Asia, Europe, and the Americas varies widely. Adult EPF tends to present in the third and fourth decades.<xref ref-type="bibr" rid="article-157076.r7">[7]</xref>&#x000a0;EPF-I most commonly presents before 12 months of age and usually resolves by 36 months.<xref ref-type="bibr" rid="article-157076.r8">[8]</xref>&#x000a0;IS-EPF is most frequently identified in patients with advanced HIV disease or acquired immunodeficiency syndrome (AIDS). Approximately 5% of patients living with HIV will develop EPF at some time following their diagnosis.</p>
        <p>All forms of EPF demonstrate a male-dominated gender predilection; the ratio of affected males to females is 5:1.<xref ref-type="bibr" rid="article-157076.r9">[9]</xref></p>
        <p>Establishing precise epidemiological data is hindered by the rarity of EPF and the lack of large-scale studies.</p>
      </sec>
      <sec id="article-157076.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of EPF is not entirely understood. Immune dysregulation appears to play a role in the pathophysiologic processes associated with IS-EPF. Studies employing reverse transcriptase polymerase chain reaction (PCR) to measure mRNA expression have found elevated levels of interleukin-4, interleukin-5, RANTES (regulated on activation, normal T cell expressed and secreted), and eotaxins in patients with IS-EPF. These cytokines and chemokines increase the expression of T cells, especially type 2 helper T cells (T<sub>H</sub>2 cells).<xref ref-type="bibr" rid="article-157076.r10">[10]</xref>&#x000a0;Eotaxins also contribute to the migration and activation of eosinophils in allergic and inflammatory conditions.<xref ref-type="bibr" rid="article-157076.r11">[11]</xref></p>
        <p>Furthermore, there are likely interactions between the skin microbiome and the immune system, judging by the variety of treatment options that have efficacy in specific patients, such as itraconazole or metronidazole.<xref ref-type="bibr" rid="article-157076.r7">[7]</xref></p>
      </sec>
      <sec id="article-157076.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The&#x000a0;3 subtypes of EPF share the same histological features characterized by a brisk eosinophilic dermal infiltrate in a nonspecific perifollicular or perivascular distribution. (see&#x000a0;<bold>Image.</bold> Eosinophilic pustular folliculitis) Additional findings include interstitial flame figures indicative of abundant eosinophil degranulation with subsequent coating of dermal collagen fibers and eosinophilic pustules at various levels, including hair follicles.<xref ref-type="bibr" rid="article-157076.r12">[12]</xref></p>
      </sec>
      <sec id="article-157076.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The&#x000a0;3 subtypes of EPF commonly present in a similar fashion. Patients with EPF usually present with recurrent crops of intensely pruritic papules and sterile pustules in a seborrheic and hair-bearing distribution.<xref ref-type="bibr" rid="article-157076.r13">[13]</xref>&#x000a0;(see&#x000a0;<bold>Image.</bold> Eosinophilic pustular folliculitis) A koebnerized distribution may also be observed during disease relapse.<xref ref-type="bibr" rid="article-157076.r14">[14]</xref></p>
        <p>Flares of EPF last approximately 1 week and remain asymptomatic following treatment for approximately 4 weeks prior to relapse.<xref ref-type="bibr" rid="article-157076.r15">[15]</xref>&#x000a0;Atypical presentations of EPF may&#x000a0;include extrafollicular plaques resembling pemphigus foliaceous.<xref ref-type="bibr" rid="article-157076.r16">[16]</xref></p>
        <p>The course of the disease will vary according to subtype. The timeline of EPF-I, presenting within the first 14 months and resolving within the first 36 months, aids in differentiating EPF-I from the commonly seen&#x000a0;erythema toxicum neonatorum and transient neonatal pustular melanosis, both of which occur in the neonatal period.<xref ref-type="bibr" rid="article-157076.r17">[17]</xref>&#x000a0;EPF-I is frequently localized to the scalp and rarely demonstrates an annular or serpiginous configuration.</p>
        <p>Classic EPF presents in middle-aged men, with most cases demonstrating serpiginous and annular groups of papules and pustules on the face, back, and trunk.&#x000a0;However, there are case reports of&#x000a0;EPF appearing on the&#x000a0;palms and soles.<xref ref-type="bibr" rid="article-157076.r18">[18]</xref>&#x000a0;EPF may also present as an isotopic response of Wolf by appearing in the area of a previously healed dermatosis.<xref ref-type="bibr" rid="article-157076.r19">[19]</xref></p>
        <p>IS-EPF predominantly presents with excoriated and eczematous follicular papules, although it may arise in koebnerized or atypical areas.<xref ref-type="bibr" rid="article-157076.r15">[15]</xref><xref ref-type="bibr" rid="article-157076.r20">[20]</xref><xref ref-type="bibr" rid="article-157076.r21">[21]</xref></p>
      </sec>
      <sec id="article-157076.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>There are many etiologies of pustular eruptions, including conditions as common as acne vulgaris and as rare as graft-versus-host disease. Routine history-taking of patients with relapsing and remitting skin eruptions should pursue the identification of any underlying chronic immunosuppression. If the pruritic erythematous papulopustular condition fails to respond to a trial of topical steroids, Nomura et al propose potassium hydroxide microscopy of skin scrapings, a mineral oil preparation for microscopic evaluation, a complete blood count, HIV testing, and biopsy of a lesion that includes a pustule and hair follicle.<xref ref-type="bibr" rid="article-157076.r22">[22]</xref></p>
      </sec>
      <sec id="article-157076.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The initial symptomatic treatment of all three subtypes of EPF is topical steroids. However, first-line therapy for classic EPF should also include indomethacin, which has shown favorable outcomes in typical and atypical presentations.<xref ref-type="bibr" rid="article-157076.r22">[22]</xref><xref ref-type="bibr" rid="article-157076.r13">[13]</xref></p>
        <p>In patients with IS-EPF, the primary goal of therapy is a return to normal T-cell levels. If the underlying immunosuppression is due to HIV infection, highly active antiretroviral therapy (HAART) should be initiated, and other medications may be used to alleviate pruritus in the interim. Symptomatic IS-EPF and recalcitrant EPF may benefit from UVB phototherapy, low-dose isotretinoin, tumor necrosis factor-alpha (TNF-&#x003b1;) inhibitors, tetracyclines, systemic corticosteroids, metronidazole, itraconazole, or topical calcineurin inhibitors.<xref ref-type="bibr" rid="article-157076.r23">[23]</xref><xref ref-type="bibr" rid="article-157076.r24">[24]</xref><xref ref-type="bibr" rid="article-157076.r25">[25]</xref><xref ref-type="bibr" rid="article-157076.r7">[7]</xref></p>
        <p>The goal of treatment for patients with EPF-I is alleviation of symptoms until the disease process spontaneously resolves; topical steroids or erythromycin may benefit.<xref ref-type="bibr" rid="article-157076.r22">[22]</xref></p>
        <p>Scabicides such as permethrin may be helpful in some HIV-associated EPF cases. Permethrin acts on the nerve cell's membrane, disrupting sodium channel current, leading to dysregulation of the membrane's polarization.<xref ref-type="bibr" rid="article-157076.r7">[7]</xref></p>
        <p>Antihistamines may help relieve itching in some instances of HIV-associated EPF. Sedating antihistamines may prove more helpful when patients experience nocturnal pruritus. Cyproheptadine can provide symptomatic relief of symptoms caused by histamine release from allergens leading to skin manifestations. Hydroxyzine antagonizes H1 receptors in the periphery, suppressing histamine action in the CNS. Cetirizine has also been used in cases of infantile EPF.<xref ref-type="bibr" rid="article-157076.r26">[26]</xref></p>
      </sec>
      <sec id="article-157076.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The&#x000a0;diagnostic protocol outlined by Nomura et al allows the astute clinician to rule in or out other common and uncommon pruritic pustular conditions such as bacterial and fungal folliculitis, seborrheic dermatitis, scabies, other arthropod assaults, pustular rosacea, and cutaneous T-cell lymphoma (mycosis fungoides). Other conditions to consider with similar signs or symptoms include photodermatitis, papular urticaria, and graft-versus-host-disease&#x000a0;in organ transplant recipients.</p>
        <p>EPF-I may present similarly to transient neonatal pustular melanosis, erythema toxicum neonatorum, acropustulosis of infancy, kerion, Langerhans cell histiocytosis, or acne neonatorum.<xref ref-type="bibr" rid="article-157076.r27">[27]</xref></p>
      </sec>
      <sec id="article-157076.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of EPF is dictated by the subtype. While classic EPF can be a chronic relapsing and remitting disease, EPF-I and IS-EPF have reliable endpoints of age and correction of underlying immunosuppression, respectively.</p>
      </sec>
      <sec id="article-157076.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of all subtypes of EPF tend to be mild and rare. However, in cases where the pustules are severe and persistent, scarring can occur&#x000a0;and distort&#x000a0;local free margins; if EPF occurs near the eyelid margin, ectropion may result.<xref ref-type="bibr" rid="article-157076.r25">[25]</xref></p>
      </sec>
      <sec id="article-157076.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The existing literature on EPF is devoid of specific deterrence measures or distinctive patient education strategies.&#x000a0;There is no evidence supporting dietary modifications or alterations in environmental exposures to alleviate the condition. Nevertheless, it is advised that patients refrain from excessive scratching of the lesions to mitigate the risk of secondary bacterial infection&#x000a0;of the sterile pustules. Adherence may be challenging due to the pruritic nature of the disease process.</p>
      </sec>
      <sec id="article-157076.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All subtypes of EPF have the potential to cause physical discomfort and negatively affect quality of life despite the benign nature of the disease process. Patients with classic EPF or EPF-I will most likely present to a primary care practitioner. Dermatology consultation will benefit patients with any subtype of EPF. Patients with chronic immunosuppression may present to the provider managing that disease process. In cases of secondary infection, infectious disease consultation may prove helpful.&#x000a0;</p>
      </sec>
      <sec id="article-157076.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=157076&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=157076">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/eosinophilic-pustular-folliculitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=157076">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/157076/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=157076">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-157076.s15">
        <fig id="article-157076.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Eosinophilic Pustular Folliculitis. Skin biopsy; hematoxylin and eosin stain. Contributed by Nishad Sathe, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Eosinophilic__pustular__folliculitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-157076.s16">
        <fig id="article-157076.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Eosinophilic Pustular Folliculitis. Papulopustular lesions with mild excoriation in seborrheic follicular distribution. Sourced from Grant et al. https://doi.org/10.1016/j.jdcr.2022.12.022. Licensing purchased from Elsevier and Copyright Clearance Center with licensing #5604250118494.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EPF-JAADCR" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-157076.s17">
        <title>References</title>
        <ref id="article-157076.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ISE</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>OFUJI</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>SUBCORNEAL PUSTULAR DERMATOSIS; A FOLLICULAR VARIANT?</article-title>
            <source>Arch Dermatol</source>
            <year>1965</year>
            <month>Aug</month>
            <volume>92</volume>
            <fpage>169</fpage>
            <page-range>169-71</page-range>
            <pub-id pub-id-type="pmid">14314743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Teraki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Konohana</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Shiohara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nagashima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis (Ofuji's disease). Immunohistochemical analysis.</article-title>
            <source>Arch Dermatol</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>129</volume>
            <issue>8</issue>
            <fpage>1015</fpage>
            <page-range>1015-9</page-range>
            <pub-id pub-id-type="pmid">7688946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayes</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Hille</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic folliculitis in 2 HIV-positive women.</article-title>
            <source>Arch Dermatol</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>140</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-5</page-range>
            <pub-id pub-id-type="pmid">15096375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Beatty</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Falcone</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>English</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kazlouskaya</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic Pustular Folliculitis in the Setting of Solid Organ Transplant Immunosuppression.</article-title>
            <source>Dermatol Pract Concept</source>
            <year>2023</year>
            <month>Apr</month>
            <day>01</day>
            <volume>13</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">37196266</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kishi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Takagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hayashi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis after hematopoietic stem cell transplantation: A study of 11 cases.</article-title>
            <source>J Dermatol</source>
            <year>2021</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>e231</fpage>
            <page-range>e231-e233</page-range>
            <pub-id pub-id-type="pmid">33715192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cernaro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tonti</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis due to naltrexone: A case report.</article-title>
            <source>J Am Pharm Assoc (2003)</source>
            <year>2022</year>
            <season>Nov-Dec</season>
            <volume>62</volume>
            <issue>6</issue>
            <fpage>1925</fpage>
            <page-range>1925-1928</page-range>
            <pub-id pub-id-type="pmid">35987727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ellis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheinfeld</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis: a comprehensive review of treatment options.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2004</year>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>189</fpage>
            <page-range>189-97</page-range>
            <pub-id pub-id-type="pmid">15186198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziemer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>B&#x000f6;er</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis in infancy: not a distinctive inflammatory disease of the skin.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>5</issue>
            <fpage>443</fpage>
            <page-range>443-55</page-range>
            <pub-id pub-id-type="pmid">16148418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takematsu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Igarashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tagami</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis. Report of two cases with a review of the Japanese literature.</article-title>
            <source>Arch Dermatol</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>121</volume>
            <issue>7</issue>
            <fpage>917</fpage>
            <page-range>917-20</page-range>
            <pub-id pub-id-type="pmid">4015140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amerio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Verdolini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Proietto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Toto</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shivji</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Loconsole</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cassano</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Amerio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vena</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sauder</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2001</year>
            <month>May</month>
            <volume>81</volume>
            <issue>2</issue>
            <fpage>92</fpage>
            <page-range>92-5</page-range>
            <pub-id pub-id-type="pmid">11501668</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amerio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Frezzolini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Verdolini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Teofoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Pit&#x000e0;</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Puddu</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.</article-title>
            <source>Curr Drug Targets Inflamm Allergy</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-94</page-range>
            <pub-id pub-id-type="pmid">14561178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fertitta</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bodemer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Molina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Frassati-Biaggi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fraitag</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leclerc-Mercier</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic Pustular Folliculitis of Infancy: A Histologic Assessment of 43 Cases.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2022</year>
            <month>Jun</month>
            <day>01</day>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>395</fpage>
            <page-range>395-403</page-range>
            <pub-id pub-id-type="pmid">35583404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Sahni</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Florell</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Hull</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Florell</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Miles</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Wada</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>An atypical case of eosinophilic pustular folliculitis with associated secondary follicular mucinosis treated with indomethacin.</article-title>
            <source>JAAD Case Rep</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>34</volume>
            <fpage>86</fpage>
            <page-range>86-89</page-range>
            <pub-id pub-id-type="pmid">37025561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sialiti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khallaayoune</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meziane</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Senouci</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Uncommon localisation of Ofuji disease in a Moroccan patient.</article-title>
            <source>BMJ Case Rep</source>
            <year>2021</year>
            <month>Apr</month>
            <day>13</day>
            <volume>14</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">33849877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nervi</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Dmochowski</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis: a 40 year retrospect.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>285</fpage>
            <page-range>285-9</page-range>
            <pub-id pub-id-type="pmid">16844513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kakurai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Furuta</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iijima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nomura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A Case of Eosinophilic Pustular Folliculitis with Vegetating Lesions on the Lower Legs and Feet Resembling Pemphigus Vegetans.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2023</year>
            <month>Apr</month>
            <day>21</day>
            <volume>103</volume>
            <fpage>adv11622</fpage>
            <pub-id pub-id-type="pmid">37083096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chadha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jahnke</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Common Neonatal Rashes.</article-title>
            <source>Pediatr Ann</source>
            <year>2019</year>
            <month>Jan</month>
            <day>01</day>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>e16</fpage>
            <page-range>e16-e22</page-range>
            <pub-id pub-id-type="pmid">30653638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuboi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Niiyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Katsuoka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis (Ofuji disease) manifested as pustules on the palms and soles.</article-title>
            <source>Cutis</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>74</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-10</page-range>
            <pub-id pub-id-type="pmid">15379363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xv</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>A Case of Isotopic Response Presented with Eosinophilic Pustular Folliculitis.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2023</year>
            <volume>16</volume>
            <fpage>1749</fpage>
            <page-range>1749-1752</page-range>
            <pub-id pub-id-type="pmid">37441695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rikitake</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kokubu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Manabe</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>11</issue>
            <fpage>2022</fpage>
            <page-range>2022-2024</page-range>
            <pub-id pub-id-type="pmid">35699624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bronte Anaut</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arredondo Montero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Arpa Nadal</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guarch Troyas</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A vulvar pseudotumor: A rare clinical presentation of eosinophilic folliculitis.</article-title>
            <source>Int J Gynaecol Obstet</source>
            <year>2022</year>
            <month>May</month>
            <volume>157</volume>
            <issue>2</issue>
            <fpage>484</fpage>
            <page-range>484-485</page-range>
            <pub-id pub-id-type="pmid">34796483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nomura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Katoh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyachi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kabashima</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis: A proposal of diagnostic and therapeutic algorithms.</article-title>
            <source>J Dermatol</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>11</issue>
            <fpage>1301</fpage>
            <page-range>1301-1306</page-range>
            <pub-id pub-id-type="pmid">27028427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buchness</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Hatcher</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Soter</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy.</article-title>
            <source>N Engl J Med</source>
            <year>1988</year>
            <month>May</month>
            <day>05</day>
            <volume>318</volume>
            <issue>18</issue>
            <fpage>1183</fpage>
            <page-range>1183-6</page-range>
            <pub-id pub-id-type="pmid">3362166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Conti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Quaglino</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ribero</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of eosinophilic pustular folliculitis with low-dose isotretinoin.</article-title>
            <source>Int J Dermatol</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>61</volume>
            <issue>7</issue>
            <fpage>e262</fpage>
            <page-range>e262-e264</page-range>
            <pub-id pub-id-type="pmid">34591315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramondetta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giuffrida</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Vincenzo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Pasquale</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A case of eosinophilic pustular folliculitis successfully treated with adalimumab.</article-title>
            <source>Dermatol Ther</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>e15550</fpage>
            <pub-id pub-id-type="pmid">35508711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odyakmaz Demirsoy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Demirsoy</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ozod</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kiran</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis of infancy suppressed with cetirizine.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2019</year>
            <month>May</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>395</fpage>
            <page-range>395-396</page-range>
            <pub-id pub-id-type="pmid">30791150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-157076.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fr&#x000f8;lunde</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Olesen</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Riber-Hansen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pallesen</surname>
                <given-names>KAU</given-names>
              </name>
            </person-group>
            <article-title>Eosinophilic pustular folliculitis of infancy: A rare diagnosis in children.</article-title>
            <source>Clin Case Rep</source>
            <year>2021</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>e04167</fpage>
            <pub-id pub-id-type="pmid">34026179</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
